Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Four Indian generic companies take sub license from MPP on daclatasvir
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Know the interactions between HIV and Hep C medicines
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
